Simultaneous determination of imipramine, desipramine and their 2- and 10-hydroxylated metabolites in human plasma and urine by high-performance liquid chromatography

J Chromatogr B Biomed Sci Appl. 1997 May 23;693(1):153-8. doi: 10.1016/s0378-4347(97)00053-4.

Abstract

A simultaneous assay for imipramine, desipramine and their 2- and 10-hydroxy-metabolites using high-performance liquid chromatography (HPLC) is described. The drugs and internal standard, pericyazine, were extracted from plasma or urine at pH 9.6 with diethyl ether and back-extracted into 0.1 M orthophosphoric acid. The recovery of the compounds ranged from 78.6% for imipramine to 94.3% for 2-hydroxydesipramine. The extracts were analysed by reversed-phase HPLC with electrochemical detection using a mobile phase of 30% acetonitrile in 0.1 M K2HPO4 at pH 6.0 delivered at 2 ml/min. All compounds were resolved in a run time of 15 min with lower limits of quantification of 1.5 ng/ml for hydroxy-metabolites and 3 ng/ml for imipramine and desipramine. The intra- and inter-day coefficients of variation at 50 ng/ml were 5.2% and 6.8%, respectively (n=8).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antidepressive Agents, Tricyclic / blood*
  • Antidepressive Agents, Tricyclic / pharmacokinetics
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Antidepressive Agents, Tricyclic / urine*
  • Chromatography, High Pressure Liquid
  • Desipramine / analogs & derivatives
  • Desipramine / blood*
  • Desipramine / pharmacokinetics
  • Desipramine / therapeutic use
  • Desipramine / urine*
  • Female
  • Humans
  • Imipramine / analogs & derivatives
  • Imipramine / blood*
  • Imipramine / pharmacokinetics
  • Imipramine / therapeutic use
  • Imipramine / urine*
  • Male
  • Middle Aged
  • Sensitivity and Specificity

Substances

  • Antidepressive Agents, Tricyclic
  • 2-hydroxyimipramine
  • 10-hydroxydesipramine
  • 10-hydroxyimipramine
  • Imipramine
  • Desipramine
  • 2-hydroxydesipramine